BAL Lazio

HTA

HTA – Risorse

Pubblicato lunedì 5 Maggio 2014

Risorse generali e reti internazionali

European network for Health Technology Assessment (EUNETHTA)
Health Technology Assessment Database (Cochrane)
Health Technology Assessment international (HTAi)
International Information Network on New and Emerging Health Technologies (EuroScan)
International Network of Agencies of Health Technology Assessment (INAHTA)

EUROPA

Italia
Agenzia nazionale per i servizi sanitari regionali (Age.Na.S.)
Società Italiana di Health Technology Assessment (SIHTA)

Austria
Ludwig Boltzmann Institut für Health Technology Assessment (LBI of HTA)

Belgio
Belgian Federal Health Care Knowledge Centre (KCE)

Danimarca
Danish Institute for Health Services Research (DSI)

Finlandia
Finnish Office for Health Technology Assessment (FinOHTA)

Francia
Comité d´Evaluation et de Diffusion des Innovations Technologiques (CEDIT)
Haute Autorité de Santé (HAS)

Germania
German Agency for HTA at the German Institute for Medical Documentation and Information (DAHTA @DIMDI)
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

Lettonia
Health Statistics and Medical Technologies State Agency (VSMTVA)

Lituania
State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania (VASPVT)

Norvegia
Norwegian Knowledge Centre for the Health Services (NOKC)

Paesi Bassi
Gezondheidsraad (GR)
The Medical and Health Research Council of The Netherlands (ZonMw)

Polonia
Agency for Health Technology Assessment in Poland (AHTAPol)

Regno Unito
Centre for Reviews and Dissemination (CRD)
Institute of Applied Health Sciences (IAHS)
National Institute for Health Research Health Technology Assessment Programme
Quality Improvement Scotland (NHS QIS)

Spagna
Agencia de Evaluación de Tecnologias Sanitarias (AETS)
Andalusian Agency for Health Technology Assessment (AETSA)
Galician Agency for Health Technology Assessment (AVALIA-T)
Catalan Agency for Health Technology Assessment and Research (CAHTA)
Basque Office for Health Technology Assessment (OSTEBA)

Svezia
Swedish Council on Technology Assessment in Health Care (SBU)

Svizzera
Medical Technology Unit – Swiss Federal Office of Public Health (MTU-SFOPH)

RESTO DEL MONDO

Argentina
Institute for Clinical Effectiveness and Health Policy (IECS)

Australia
Adelaide Health Technology Assessment (AHTA)
Medical Services Advisory Committee (MSAC)

Brasile
Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia (DECIT-CGATS)

Canada
Agence d´Évaluation des Technologies et des Modes d´Intervention en Santé (AETMIS)
Canadian Agency for Drugs and Technologies in Health (CADTH)
Institute of Health Economics (IHE)

Malesia
Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)

Messico
Centro Nacional de Excelencia Tecnológica en Salud (CENETEC)

Nuova Zelanda
Health Services Assessment Collaboration (HSAC)

Taiwan
Center for Drug Evaluation (CDE)

USA
Agency for Healthcare Research and Quality (AHRQ)

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Razaz N et al. Association between Apgar scores of 7 to 9 and neonatal mortality and morbidity: population based cohort study of term infants in Sweden. BMJ 2019; 365:1656.

Razaz N et al One-minute and five-minute Apgar scores and child developmental health at 5 years of age: a population-based cohort study in British Columbia, Canada BMJ Open 2019;9:e027655.

European Association for the Study of Obesity. Pregnant women who were overweight children are at increased risk of developing hypertensive disorders.

Spinelli A et al. Prevalence of severe obesity among primary school children in 21 european countries. Obes Facts 2019;12:244-258.

Akyea RK et al. Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart Published Online First: 15 April 2019. doi: 10.1136/heartjnl-2018-314253.

Qaseem A et al.; for the Clinical Guidelines Committee of the American College of Physicians. Screening for breast cancer in average-risk women: a guidance statement from the american college of physicians. Ann Intern Med. [Epub ahead of print 9 April 2019] doi: 10.7326/M18-2147.

Elmore JG, Lee CI. A guide to a guidance statement on screening guidelines. Ann Intern Med. [Epub ahead of print 9 April 2019] doi: 10.7326/M19-0726.

Feldman AG et al. Incidence of hospitalization for vaccine-preventable infections in children following solid organ transplant and associated morbidity, mortality, and costs. JAMA Pediatr. 2019 Jan 14. [Epub ahead of print]

Feldman AG et al. Hospitalizations for respiratory syncytial virus and vaccine-preventable infections in the first 2 years after pediatric liver transplant. J Pediatr 2017;182:232-238.e1.

Feldman AG et al. Immunization practices among pediatric transplant hepatologists. Pediatr Transplantation 2016;20:1038-1044.

Rubin LG et al.; Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58(3):e44-100.

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.